{"id":"W4396591214","doi":"10.1158/1538-7445.sabcs23-po3-17-10","title":"Abstract PO3-17-10: Real-World evidence for Pembrolizumab-based neoadjuvant chemotherapy in early-stage triple negative breast cancer: a single institution experience","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Pembrolizumab; Medicine; Breast cancer; Stage (stratigraphy); Oncology; Chemotherapy; Cancer; Internal medicine; Neoadjuvant therapy; Triple-negative breast cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01673591,0.0002508555,0.0005890693,0.0005058289,0.0002882902,0.002055264,0.000631299,0.0004025591,0.003048697],"category_scores_gemma":[0.0238965,0.0001817817,0.0006531588,0.0009268979,0.0005766834,0.0007152624,0.0007384553,0.0005084935,0.0004615676],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000975231,"about_ca_system_score_gemma":0.002386257,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007021768,"about_ca_topic_score_gemma":0.002054028,"domain_scores_codex":[0.9925931,0.004846619,0.001075442,0.0003394928,0.0009355835,0.0002096587],"domain_scores_gemma":[0.9767411,0.01078688,0.007415688,0.001552593,0.002281679,0.001222016],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.02097849,0.004092811,0.3949759,0.009098665,0.005603192,0.001090535,0.002322764,0.001320773,0.007756115,0.001558767,0.008043416,0.5431585],"study_design_scores_gemma":[0.009545007,0.07334266,0.724896,0.02729437,0.01122194,0.01184112,0.008232313,0.004026328,0.01194851,0.001666436,0.1156892,0.0002961271],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.943293,0.04241925,0.001761736,0.002335345,0.0001359378,0.0008995171,0.001286241,0.00003063241,0.007838316],"genre_scores_gemma":[0.9826173,0.01143338,0.003425521,0.0008264765,0.0001332482,0.0003622558,0.0007380256,0.00002040897,0.0004434169],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01673591,"threshold_uncertainty_score":0.08850902,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1191619086055209,"score_gpt":0.4095606535959698,"score_spread":0.2903987449904489,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}